ID   BMP2K_HUMAN             Reviewed;        1161 AA.
AC   Q9NSY1; O94791; Q4W5H2; Q8IYF2; Q8N2G7; Q8NHG9; Q9NTG8;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   12-OCT-2022, entry version 189.
DE   RecName: Full=BMP-2-inducible protein kinase {ECO:0000250|UniProtKB:Q91Z96};
DE            Short=BIKe {ECO:0000250|UniProtKB:Q91Z96};
DE            EC=2.7.11.1 {ECO:0000269|PubMed:26853940};
GN   Name=BMP2K; Synonyms=BIKE; ORFNames=HRIHFB2017;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Synovium, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT SER-405.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 537-1161 (ISOFORM 2).
RC   TISSUE=Ovary;
RA   Guo J.H., Yu L.;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 946-1161 (ISOFORM 1), AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=9853615; DOI=10.1038/4315;
RA   Ueki N., Oda T., Kondo M., Yano K., Noguchi T., Muramatsu M.-A.;
RT   "Selection system for genes encoding nuclear-targeted proteins.";
RL   Nat. Biotechnol. 16:1338-1342(1998).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1107, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-834 AND SER-1076, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-1107, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029 AND SER-1032, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029; SER-1107 AND SER-1111,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-689; SER-742; SER-817;
RP   SER-818; SER-1029; SER-1032; SER-1041; SER-1107 AND SER-1111, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-1039, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16] {ECO:0007744|PDB:4W9W, ECO:0007744|PDB:4W9X}
RP   X-RAY CRYSTALLOGRAPHY (1.72 ANGSTROMS) OF 39-344 IN COMPLEX WITH
RP   INHIBITORS, AND CATALYTIC ACTIVITY.
RX   PubMed=26853940; DOI=10.1016/j.str.2015.12.015;
RA   Sorrell F.J., Szklarz M., Abdul Azeez K.R., Elkins J.M., Knapp S.;
RT   "Family-wide Structural Analysis of Human Numb-Associated Protein
RT   Kinases.";
RL   Structure 24:401-411(2016).
RN   [17] {ECO:0007744|PDB:5I3O, ECO:0007744|PDB:5I3R}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 42-343.
RA   Counago R.M., Sorrell F.J., Krojer T., Elkins J.M., Gileadi O.,
RA   Willson T.M., Arrowsmith C.H., Edwards A.M., Bountra C., Arruda P.;
RT   "Crystal Structure of BMP-2-inducible kinase in complex with an Indazole
RT   inhibitor.";
RL   Submitted (FEB-2016) to the PDB data bank.
RN   [18] {ECO:0007744|PDB:5IKW}
RP   X-RAY CRYSTALLOGRAPHY (2.41 ANGSTROMS) OF 38-345.
RA   Counago R.M., Sorrell F.J., Krojer T., Savitsky P., Elkins J.M., Axtman A.,
RA   Drewry D., Wells C., Zhang C., Zuercher W., Willson T.M., Arrowsmith C.H.,
RA   Edwards A.M., Bountra C., Arruda P., Gileadi O.;
RT   "Crystal Structure of BMP-2-inducible kinase in complex with a 3-
RT   acylaminoindazole inhibitor GSK3236425A.";
RL   Submitted (MAR-2016) to the PDB data bank.
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-68; VAL-212 AND HIS-288.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May be involved in osteoblast differentiation.
CC       {ECO:0000250|UniProtKB:Q91Z96}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:26853940};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:26853940};
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9853615}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NSY1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NSY1-2; Sequence=VSP_008091, VSP_008092;
CC       Name=3;
CC         IsoId=Q9NSY1-3; Sequence=VSP_008093, VSP_008091, VSP_008092;
CC   -!- PTM: Autophosphorylated. {ECO:0000250|UniProtKB:Q91Z96}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK075278; BAC11515.1; -; mRNA.
DR   EMBL; AK292147; BAF84836.1; -; mRNA.
DR   EMBL; AL137275; CAB70673.1; -; mRNA.
DR   EMBL; AL137661; CAB70863.1; -; mRNA.
DR   EMBL; AC098818; AAY40926.1; -; Genomic_DNA.
DR   EMBL; BC036021; AAH36021.1; -; mRNA.
DR   EMBL; AF527532; AAM88867.1; -; mRNA.
DR   EMBL; AB015331; BAA34790.1; -; mRNA.
DR   CCDS; CCDS34019.1; -. [Q9NSY1-2]
DR   CCDS; CCDS47083.1; -. [Q9NSY1-1]
DR   PIR; T46347; T46347.
DR   PIR; T46364; T46364.
DR   RefSeq; NP_060063.2; NM_017593.3. [Q9NSY1-2]
DR   RefSeq; NP_942595.1; NM_198892.1. [Q9NSY1-1]
DR   PDB; 4W9W; X-ray; 1.72 A; A=39-344.
DR   PDB; 4W9X; X-ray; 2.14 A; A=38-345.
DR   PDB; 5I3O; X-ray; 2.40 A; A/B=42-343.
DR   PDB; 5I3R; X-ray; 2.40 A; A/B=42-343.
DR   PDB; 5IKW; X-ray; 2.41 A; A=38-345.
DR   PDBsum; 4W9W; -.
DR   PDBsum; 4W9X; -.
DR   PDBsum; 5I3O; -.
DR   PDBsum; 5I3R; -.
DR   PDBsum; 5IKW; -.
DR   AlphaFoldDB; Q9NSY1; -.
DR   SMR; Q9NSY1; -.
DR   BioGRID; 120735; 97.
DR   IntAct; Q9NSY1; 62.
DR   MINT; Q9NSY1; -.
DR   STRING; 9606.ENSP00000334836; -.
DR   BindingDB; Q9NSY1; -.
DR   ChEMBL; CHEMBL4522; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9NSY1; -.
DR   GuidetoPHARMACOLOGY; 1941; -.
DR   GlyGen; Q9NSY1; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9NSY1; -.
DR   PhosphoSitePlus; Q9NSY1; -.
DR   BioMuta; BMP2K; -.
DR   DMDM; 34222653; -.
DR   EPD; Q9NSY1; -.
DR   jPOST; Q9NSY1; -.
DR   MassIVE; Q9NSY1; -.
DR   MaxQB; Q9NSY1; -.
DR   PaxDb; Q9NSY1; -.
DR   PeptideAtlas; Q9NSY1; -.
DR   PRIDE; Q9NSY1; -.
DR   ProteomicsDB; 82594; -. [Q9NSY1-1]
DR   ProteomicsDB; 82595; -. [Q9NSY1-2]
DR   ProteomicsDB; 82596; -. [Q9NSY1-3]
DR   Antibodypedia; 24948; 194 antibodies from 26 providers.
DR   DNASU; 55589; -.
DR   Ensembl; ENST00000502613.3; ENSP00000424668.2; ENSG00000138756.19. [Q9NSY1-1]
DR   Ensembl; ENST00000502871.5; ENSP00000421768.1; ENSG00000138756.19. [Q9NSY1-2]
DR   GeneID; 55589; -.
DR   KEGG; hsa:55589; -.
DR   MANE-Select; ENST00000502613.3; ENSP00000424668.2; NM_198892.2; NP_942595.1.
DR   UCSC; uc003hlj.4; human. [Q9NSY1-1]
DR   CTD; 55589; -.
DR   DisGeNET; 55589; -.
DR   GeneCards; BMP2K; -.
DR   HGNC; HGNC:18041; BMP2K.
DR   HPA; ENSG00000138756; Low tissue specificity.
DR   MIM; 617648; gene.
DR   neXtProt; NX_Q9NSY1; -.
DR   OpenTargets; ENSG00000138756; -.
DR   PharmGKB; PA134992822; -.
DR   VEuPathDB; HostDB:ENSG00000138756; -.
DR   eggNOG; KOG1989; Eukaryota.
DR   GeneTree; ENSGT00940000157548; -.
DR   HOGENOM; CLU_000288_109_5_1; -.
DR   InParanoid; Q9NSY1; -.
DR   OMA; PWHPSHQ; -.
DR   OrthoDB; 826336at2759; -.
DR   PhylomeDB; Q9NSY1; -.
DR   TreeFam; TF335936; -.
DR   PathwayCommons; Q9NSY1; -.
DR   SignaLink; Q9NSY1; -.
DR   BioGRID-ORCS; 55589; 19 hits in 1108 CRISPR screens.
DR   ChiTaRS; BMP2K; human.
DR   GeneWiki; BMP2K; -.
DR   GenomeRNAi; 55589; -.
DR   Pharos; Q9NSY1; Tchem.
DR   PRO; PR:Q9NSY1; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q9NSY1; protein.
DR   Bgee; ENSG00000138756; Expressed in adrenal tissue and 195 other tissues.
DR   ExpressionAtlas; Q9NSY1; baseline and differential.
DR   Genevisible; Q9NSY1; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0035612; F:AP-2 adaptor complex binding; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019208; F:phosphatase regulator activity; IBA:GO_Central.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0030500; P:regulation of bone mineralization; IBA:GO_Central.
DR   GO; GO:2000369; P:regulation of clathrin-dependent endocytosis; IBA:GO_Central.
DR   InterPro; IPR026105; BMP-2-ind_kinase.
DR   InterPro; IPR028182; BMP2K_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR22967:SF10; PTHR22967:SF10; 1.
DR   Pfam; PF15282; BMP2K_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..1161
FT                   /note="BMP-2-inducible protein kinase"
FT                   /id="PRO_0000085663"
FT   DOMAIN          51..316
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          358..439
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          453..495
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          610..630
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          655..832
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          965..1035
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1137..1161
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        358..395
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        453..484
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        699..737
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        738..753
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        754..776
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        981..995
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        180
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         57..65
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         79
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         689
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         742
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         817
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         818
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         834
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   MOD_RES         928
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Z96"
FT   MOD_RES         1029
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         1031
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Z96"
FT   MOD_RES         1032
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1039
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1041
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1076
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   MOD_RES         1107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1111
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         330..340
FT                   /note="NSSIPSALPEP -> KCCKQLLRHGALLTEILLFLQLFLNR (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_008093"
FT   VAR_SEQ         651..662
FT                   /note="NRLEERASSDKN -> SKGHLKAYFASQ (in isoform 2 and
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|Ref.5"
FT                   /id="VSP_008091"
FT   VAR_SEQ         663..1161
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|Ref.5"
FT                   /id="VSP_008092"
FT   VARIANT         68
FT                   /note="V -> M (in a lung squamous cell carcinoma sample;
FT                   somatic mutation; dbSNP:rs770167074)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040388"
FT   VARIANT         212
FT                   /note="D -> V (in dbSNP:rs56143363)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040389"
FT   VARIANT         288
FT                   /note="R -> H (in dbSNP:rs55782848)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040390"
FT   VARIANT         405
FT                   /note="G -> S (in dbSNP:rs2288255)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_051618"
FT   VARIANT         486
FT                   /note="Q -> H (in dbSNP:rs2114202)"
FT                   /id="VAR_059765"
FT   VARIANT         1002
FT                   /note="T -> S (in dbSNP:rs12507099)"
FT                   /id="VAR_051619"
FT   CONFLICT        342
FT                   /note="T -> A (in Ref. 4; AAH36021)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        471..486
FT                   /note="Missing (in Ref. 2; CAB70863)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        478
FT                   /note="Q -> R (in Ref. 4; AAH36021)"
FT                   /evidence="ECO:0000305"
FT   STRAND          43..46
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   STRAND          49..59
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   STRAND          64..70
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   STRAND          75..85
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           86..102
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   STRAND          111..118
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   STRAND          120..122
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   STRAND          124..131
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           138..144
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   TURN            145..148
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           152..170
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   STRAND          172..174
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           183..185
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   STRAND          186..188
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   STRAND          194..196
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           199..201
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           209..212
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           214..224
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           227..229
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           232..234
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           245..261
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   TURN            265..268
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           270..275
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           288..297
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           302..304
FT                   /evidence="ECO:0007829|PDB:4W9W"
FT   HELIX           308..318
FT                   /evidence="ECO:0007829|PDB:4W9W"
SQ   SEQUENCE   1161 AA;  129172 MW;  5C38A86E95935EC2 CRC64;
     MKKFSRMPKS EGGSGGGAAG GGAGGAGAGA GCGSGGSSVG VRVFAVGRHQ VTLEESLAEG
     GFSTVFLVRT HGGIRCALKR MYVNNMPDLN VCKREITIMK ELSGHKNIVG YLDCAVNSIS
     DNVWEVLILM EYCRAGQVVN QMNKKLQTGF TEPEVLQIFC DTCEAVARLH QCKTPIIHRD
     LKVENILLND GGNYVLCDFG SATNKFLNPQ KDGVNVVEEE IKKYTTLSYR APEMINLYGG
     KPITTKADIW ALGCLLYKLC FFTLPFGESQ VAICDGNFTI PDNSRYSRNI HCLIRFMLEP
     DPEHRPDIFQ VSYFAFKFAK KDCPVSNINN SSIPSALPEP MTASEAAARK SQIKARITDT
     IGPTETSIAP RQRPKANSAT TATPSVLTIQ SSATPVKVLA PGEFGNHRPK GALRPGNGPE
     ILLGQGPPQQ PPQQHRVLQQ LQQGDWRLQQ LHLQHRHPHQ QQQQQQQQQQ QQQQQQQQQQ
     QQQQQQHHHH HHHHLLQDAY MQQYQHATQQ QQMLQQQFLM HSVYQPQPSA SQYPTMMPQY
     QQAFFQQQML AQHQPSQQQA SPEYLTSPQE FSPALVSYTS SLPAQVGTIM DSSYSANRSV
     ADKEAIANFT NQKNISNPPD MSGWNPFGED NFSKLTEEEL LDREFDLLRS NRLEERASSD
     KNVDSLSAPH NHPPEDPFGS VPFISHSGSP EKKAEHSSIN QENGTANPIK NGKTSPASKD
     QRTGKKTSVQ GQVQKGNDES ESDFESDPPS PKSSEEEEQD DEEVLQGEQG DFNDDDTEPE
     NLGHRPLLMD SEDEEEEEKH SSDSDYEQAK AKYSDMSSVY RDRSGSGPTQ DLNTILLTSA
     QLSSDVAVET PKQEFDVFGA VPFFAVRAQQ PQQEKNEKNL PQHRFPAAGL EQEEFDVFTK
     APFSKKVNVQ ECHAVGPEAH TIPGYPKSVD VFGSTPFQPF LTSTSKSESN EDLFGLVPFD
     EITGSQQQKV KQRSLQKLSS RQRRTKQDMS KSNGKRHHGT PTSTKKTLKP TYRTPERARR
     HKKVGRRDSQ SSNEFLTISD SKENISVALT DGKDRGNVLQ PEESLLDPFG AKPFHSPDLS
     WHPPHQGLSD IRADHNTVLP GRPRQNSLHG SFHSADVLKM DDFGAVPFTE LVVQSITPHQ
     SQQSQPVELD PFGAAPFPSK Q
//
